Several TAAs have been identified and targeted via MHC class I pathways in colorectal cancer, including p53, β-human chorionic gonadotropin (β-hCG), SART3, carcinoembryonic antigen (CEA), mucin-1 (MUC1), and Survivin-2B [106]. Here, CEACAM5 is linked to colorectal cancer.